Estimated net proceeds from convertible notes offering
Company: Core Scientific
The claim, verbatim
Net proceeds from the offering are estimated at approximately $608.7 million after deducting initial purchasers' discounts, commissions, and estimated offering expenses
Source (primary)
Core Scientific 8-K filed 2024-12-05 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “The Company estimates that the net proceeds from the Offering will be approximately $608.7 million, after deducting the initial purchasers' discounts and commissions and the Company's estimated offering expenses.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific 8-K filed 2024-12-05
Quote: “The Company estimates that the net proceeds from the Offering will be approximately $608.7 million, after deducting the initial purchasers' discounts and commissions and the Company's estimated offering expenses.”